Catalyst Wire Dossier Catalyst Wire Dossier

ELELYSO

TALIGLUCERASE ALFA · Pfizer Laboratories Div Pfizer Inc
Drug timelines are a Plus or Pro feature.

20 regulatory and trial events tracked for ELELYSO, covering 2012-05-01 to 2025-12-22. Get the full timeline:

Most recent: FDA Approved: ELELYSO — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

See pricing